Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ) SHZ

1.58

+0.02(+1.28%)

Updated at August 15 08:49AM

Currency In CNY

Valuation

Market Cap14.09B
Enterprise Value11.35B
P/E Ratio-23.43
PEG Ratio-1.52
Price/Sales Ratio0.23
Price/Book Ratio0.36
Enterprise/Revenue0.51
Enterprise/EBITDA6.36

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin-0.01
Operating Margin-0.01

Management Effectiveness

Return On Assets-0
Return On Equity-0.02

Income Statement

Revenue49.7B
Revenue/Share6.78
Gross Profit39.87B
EBITDA1.22B
Net Income-651.76M
Diluted EPS-0.13

Balance Sheet

Total Cash10.57B
Total Cash/Share2.14
Total Debt17.56B
Total Debt/Equity0.81
Current Ratio2.02
Book Value Per Share7.29

Price History

52-Week Change-53.67
52-Week High5.42
52-Week Low1.35
Moving Average 50 Days2.23
Moving Average 200 Days3.43

Statistics

Average Volume52.4M
Shares Outstanding4.9B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-1.37
Last Split Factor37:20
Last Split DateApril 12, 2010